概述

  • 产品名称Anti-FHL1抗体
    参阅全部 FHL1 一抗
  • 描述
    山羊多克隆抗体to FHL1
  • 特异性ab26072 is specific for SLIMMER / FHL1 isoform B.
  • 经测试应用适用于: ELISA, WB, ICC/IF, IHC-Frmore details
  • 种属反应性
    与反应: Mouse, Human, Pig
  • 免疫原

    Synthetic peptide:

    CTVSRVSHPVSKARK

    , corresponding to amino acids 233 - 246 of Human FHL1

  • 阳性对照
    • Human Heart lysate

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • 存储溶液Preservative: 0.02% Sodium Azide
    Constituents: Tris buffered saline, 0.5mg/ml BSA. pH 7.3
  • Concentration information loading...
  • 纯度Immunogen affinity purified
  • 纯化说明Purified by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab26072 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA
WB
ICC/IF
IHC-Fr
  • 应用说明ELISA: 1/128000.
    ICC/IF: Use at an assay dependent dilution (PMID 19643733).
    IHC-Fr: Use at an assay dependent dilution (PMID 19643733).
    WB: Use at a concentration of 0.01 - 0.1 µg/ml. Predicted molecular weight: 36 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能May have an involvement in muscle development or hypertrophy.
    • 组织特异性Isoform 1 is highly expressed in skeletal muscle and to a lesser extent in heart, placenta, ovary, prostate, testis, small intestine, colon and spleen. Expression is barely detectable in brain, lung, liver, kidney, pancreas, thymus and peripheral blood leukocytes. Isoform 2 is expressed in brain, skeletal muscle and to a lesser extent in heart, colon, prostate and small intestine. Isoform 3 is expressed in testis, heart and skeletal muscle.
    • 疾病相关Defects in FHL1 are the cause of X-linked dominant scapuloperoneal myopathy (SPM) [MIM:300695]. Scapuloperoneal syndrome (SPS) was initially described more than 120 years ago by Jules Broussard as 'une forme hereditaire d'atrophie musculaire progressive' beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. The etiology of this condition remains unclear.
      Defects in FHL1 are the cause of X-linked myopathy with postural muscle atrophy (XMPMA) [MIM:300696]. Myopathies are inherited muscle disorders characterized by weakness and atrophy of voluntary skeletal muscle, and several types of myopathy also show involvement of cardiac muscle. XMPMA is a distinct form of adult-onset X-linked recessive myopathy with several features in common with other myopathies, but the presentation of a pseudoathletic phenotype, scapuloperoneal weakness, and bent spine is unique and might render the clinical phenotype distinguishable from other myopathies.
      Defects in FHL1 are the cause of X-linked severe early-onset reducing body myopathy (RBM) [MIM:300717]. RBM is a rare muscle disorder causing progressive muscular weakness and characteristic intracytoplasmic inclusions in myofibers. Clinical presentations of RBM have ranged from early onset fatal to childhood onset to adult onset cases.
      Defects in FHL1 are the cause of X-linked childhood-onset reducing body myopathy (CO-RBM) [MIM:300718]. This disorder is allelic to severe early-onset reducing body myopathy (RBM) [MIM:300717].
    • 序列相似性Contains 3 LIM zinc-binding domains.
    • 发展阶段Elevated levels during postnatal muscle growth.
    • 细胞定位Cytoplasm; Cytoplasm. Nucleus and Nucleus. Cytoplasm > cytosol. Predominantly nuclear in myoblasts but is cytosolic in differentiated myotubes.
    • Information by UniProt
    • 数据库链接
    • 别名
      • bA535K18.1 antibody
      • FHL 1 antibody
      • FHL 1B antibody
      • FHL-1 antibody
      • FHL1 antibody
      • FHL1 protein antibody
      • FHL1_HUMAN antibody
      • FHL1A antibody
      • FHL1B antibody
      • FLH1A antibody
      • Four and a half LIM domains 1 antibody
      • Four and a half LIM domains protein 1 antibody
      • Four and a half Lin11 Isl 1 and Mec 3 domains 1 antibody
      • four-and-a-half Lin11 antibody
      • Isl-1 and Mec-3 antibody
      • KYO T antibody
      • KYOT, mouse, homolog of antibody
      • LIM protein SLIMMER antibody
      • MGC111107 antibody
      • RAM14-1 antibody
      • RBMX1A antibody
      • RBMX1B antibody
      • RBP associated molecule 14-1 antibody
      • RP11-535K18.1 antibody
      • Skeletal muscle LIM protein 1 antibody
      • Skeletal muscle LIM-protein 1 antibody
      • SLIM 1 antibody
      • SLIM antibody
      • SLIM-1 antibody
      • SLIM1 antibody
      • SLIMMER antibody
      • XMPMA antibody
      see all

    Anti-FHL1 antibody 图像

    • Anti-FHL1 antibody (ab26072) at 0.1 µg/ml

      Predicted band size : 36 kDa


      Exposure time : 1 hour

    Anti-FHL1 antibody (ab26072)参考文献

    This product has been referenced in:
    • Cottle DL  et al. SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. J Biol Chem 284:26964-77 (2009). WB, ICC/IF, IHC-Fr ; Mouse . Read more (PubMed: 19643733) »

    See 1 Publication for this product

    Product Wall

    Thank you for contacting us.

    I am sorry to hear you have been experiencing problems with ab26072. The quality of our products is important to us and I would like to reassure you that we investigate all customer complaints.

    In order ...

    Read More
    Application Western blot
    Sample Mouse Cell lysate - other (C2C12 myoblasts)
    Loading amount 100 µg
    Specification C2C12 myoblasts
    Gel Running Conditions Reduced Denaturing
    Blocking step Milk as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 25°C
    Username

    Abcam user community

    Verified customer

    提交于 Nov 26 2007

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"